undamentalytics Newsletter
Sign in

Nexalin Technology, Inc. key statistics and ratios

In fiscal 2025, Nexalin Technology, Inc. had a net margin of -2725.8%. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.

Financial ratios

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Net margin<−999%−128.5%<−999%<−999%<−999%<−999%
Return on equity—−89.4%−107.0%———
Return on assets−806.4%−41.5%−84.0%−193.7%−185.6%−235.3%
R&D as % of revenue96.5%38.7%>999%705.8%359.2%627.4%
SG&A as % of revenue>999%112.9%>999%>999%>999%>999%

Returns use average equity or assets over the year. Return on equity is left blank when equity is negative or so small that the ratio says nothing (above ±200%); interest cover is left blank above 200 times. Price-based ratios such as P/E are on the valuation page.

Financial health

3 of 3 checks passed · June 30, 2026
What it owns · $3m
Short-term assets $2mLonger-term assets $1m
What it owes, and who funded it · $3m
Short-term liabilities $1mLonger-term liabilities $0mShareholders' equity $2m
  • Short-term assets cover short-term liabilities $2m of assets due within a year against $1m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $2m short-term assets against $0 of longer-dated liabilities.
  • More cash than debt Cash or debt not separately reported. Not assessable.
  • Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt Cash flow or debt not reported. Not assessable.
  • Operating profit covers interest at least five times over Operating income of −$9m against −$2,610 of interest.

From Nexalin Technology, Inc.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Moat

Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Low.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Compare with peers

Head to head: NXL vs QTEXNXL vs PAVMNXL vs POAS

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Nexalin Technology, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Nexalin Technology, Inc.